WIA
RPRX icon

World Investment Advisors’s Royalty Pharma RPRX Stock Holding History

World Investment Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$548K Buy
10,301
+352
+4% +$18.3K 0.01% 924
2026
Q1 		$477K Sell
9,949
-48,485
-83% -$2.12M 0.01% 1009
2025
Q4 		$2.26M Buy
58,434
+10,178
+21% +$388K 0.04% 435
2025
Q3 		$1.7M Buy
+48,256
New +$1.75M 0.03% 441

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

World Investment Advisors's RPRX Position: Q2 2026 in Review

World Investment Advisors increased its Royalty Pharma (RPRX) stake by 3.5% in Q2 2026, buying an estimated $18.3K and bringing the position to 10,301 shares worth $548K. The position accounts for 0.01% of the portfolio, ranked #924.

World Investment Advisors first reported a position in RPRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.26M in Q4 2025. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • World Investment Advisors held 10,301 shares of Royalty Pharma worth $548K as of Q2 2026.
  • World Investment Advisors bought 352 Royalty Pharma shares in Q2 2026, an estimated $18.3K.
  • Royalty Pharma made up 0.01% of World Investment Advisors's portfolio in Q2 2026, its #924 holding.
  • World Investment Advisors first reported a position in Royalty Pharma in Q3 2025 and has held it in 4 quarters since.
  • World Investment Advisors's Royalty Pharma position peaked at $2.26M in Q4 2025.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.